Portal de Periódicos da CAPES

Antiprogestins in the Induction of Labor

1994; Wiley; Volume: 734; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1994.tb21770.x

1749-6632

Kristof Chwalisż, Robert E. Garfield,

Reproductive Health and Contraception

Annals of the New York Academy of SciencesVolume 734, Issue 1 p. 387-413 Antiprogestins in the Induction of Labor KRISTOF CHWALISZ, KRISTOF CHWALISZ Research Laboratories of Schering AG Berlin, Germany Present address: Gynecologic Research, Fertility Control and Hormone Therapy Research, Berlex Laboratories, 300 Fairfield Road, Wayne, NJ 07470–7358.Search for more papers by this authorROBERT E. GARFIELD, ROBERT E. GARFIELD Research Laboratories of Schering AG Berlin, Germany Division of Reproductive Sciences Department of Obstetrics and Gynecology The University of Texas, Medical Branch Galveston, Texas 77550Search for more papers by this author KRISTOF CHWALISZ, KRISTOF CHWALISZ Research Laboratories of Schering AG Berlin, Germany Present address: Gynecologic Research, Fertility Control and Hormone Therapy Research, Berlex Laboratories, 300 Fairfield Road, Wayne, NJ 07470–7358.Search for more papers by this authorROBERT E. GARFIELD, ROBERT E. GARFIELD Research Laboratories of Schering AG Berlin, Germany Division of Reproductive Sciences Department of Obstetrics and Gynecology The University of Texas, Medical Branch Galveston, Texas 77550Search for more papers by this author First published: September 1994 https://doi.org/10.1111/j.1749-6632.1994.tb21770.xCitations: 33 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Keirse, M. J. N. 1992. Therapeutic use of prostaglandins. Ballière's Clin. Obstet. Gynecol. 6: 787–809. 2 Csapo, A. I. 1981. Force of labour. In Principles and Practice of Obstetrics and Perinatology. L. Iffy & H. A. Kaminetzky, Eds. Vol. 2: 761–799. John Wiley & Sons. New York . 3 Elger, W. 1979. Pharmacology of parturition and abortion. Anim. Reprod. Sci. 2: 133–148. 4 Porter, D. G. 1970. The failure of progesterone to affect myometrial activity in the guinea pig. J. Endocrinol. 46: 425–434. 5 Elger, W., K. Chwalisz, M. Fähnrich, S. H. Hasan, D. Laurent, S. Beier, E. Ottow, G. Neef & R. E. Garfield. 1990. Studies on labour-conditioning and labour-inducing effects of antiprogesterones in animal models. In: Uterine Contractility: Mechanisms of Control. R. E. Garfield, Ed. 153–157. Serono Symposia, USA. Norwell , MA . 6 Garfield, R. E. & C. Yallampalli. 1993. Control of myometrial contractility and labor. In Basic Mechanisms Controlling Term and Preterm Labor. Ernst Schering Research Foundation Workshop 7. K. Chwalisz & R. E. Garfield, Eds. 1–29. Springer Verlag. Berlin , Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest . 7 Chwalisz, K. 1993. Role of progesterone in the control of labor. In Basic Mechanisms Controlling Term and Preterm Labor. Ernst Schering Research Foundation Workshop 7. K. Chwalisz & R. E. Garfield, Eds. 97–163. Springer Verlag. Berlin , Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest . 8 Chwalisz, K. 1994. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Hum. Reprod. In press. 9 Philibert, D., M. Moguilewsky, M. Mary, D. Lecaque, C. Tournemine, J. Secchi & R. Deraedt. 1985. Pharmacological profile of RU 486 in animals. In The Antiprogesterone Steroid RU 486 and Human Fertility Control. E. E. Baulieu & S. J. Segal, Eds. 49–68. Plenum Press. New York . 10 Neff, G., S. Beier, W. Elger, D. Henderson & R. Wiechert. 1984. New steroids with antiprogestational and antiglucocorticoid activities. Steroids 44: 349–372. 11 Elger, W., S. Beier, K. Chwalisz, M. Fähnrich, S. H. Hasan, D. Henderson, G. Neef & R. Rohde. 1986. Studies on the mechanism of action of progesterone antagonists. J. Steroid Biochem. 25: 835–845. 12 Meyer, M. E., A. Pornon, J. Jingwei, M. T. Bocquel, P. Chambon & H. Gronemeyer. 1990. Agonistic and antagonistic activities of RU 486 on the functions of the human progesterone receptor. EMBO J. 12: 3923–3932. 13 Horwitz, K. B. 1992. The molecular biology of RU 486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr. Rev. 13 (2): 146–163. 14 Gronemeyer, H., B. Benhamou, M. Berry, M. T. Bocquel, D. Gofflo, T. Garcia, T. Lerouge, D. Metzer, M. E. Meyer, L. Tora, A. Vergezac & P. Chambon. 1992. Mechanism of antihormone action. J. Steroid Biochem. Mol. Biol. 41: 217–221. 15 Koering, M. J., D. L. Healy & G. D. Hodgen. 1986. Morphologic response of endometrium to a progesterone receptor antagonist, RU 486, in monkeys. Fertil. Steril. 45: 280–287. 16 Gravanis, A., G. Schaison, M. George, J. de Brux, P. G. Satyaswaroop, E. E. Baulieu & P. Robel. 1985. Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women. J. Clin. Endocrinol. Metab. 60: 156–163. 17 Klein-Hitpass, L., A. C. B. Cato, D. Henderson & G. U. Ryffel. 1991. Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucleic Acids Res. 19: 1227–1234. 18 Takimoto, G. S., D. M. Tasset, A. C. Eppert & K. B. Horwitz. 1992. Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK 89 299. Proc. Natl. Acad. Sci. USA 89: 3050–3054. 19 Beck, C. A., N. L. Weigel, N. L. Moyer, S. K. Nordeen & D. P. Edwards. 1993. The progesterone antagonist RU 486 acquires agonistic activity upon stimulation of cAMP signaling pathways. Proc. Natl. Acad. Sci. USA 90: 441–445. 20 Chwalisz, K., H. Altmann & W. Elger. 1986. Induction of premature parturition in the rat with antigestagens. Acta Endocrinol. (Suppl.) 111: 12 (abstract). 21 Bosc, M. J., G. Germain, A. Nicolle, M. Mouren, D. Philibert & E. E. Baulieu. 1987. Control of birth in rats by RU 486, an antiprogesterone compound. J. Reprod. Fertil. 79: 1–8. 22 Garfield, R. E., J. M. Gasc & E. E. Baulieu. 1987. Effect of the antiprogesterone RU 486 on preterm birth in the rat. Am. J. Obstet. Gynecol. 157: 1281–1285. 23 Höfig, A., W. Eiger, K. Chwalisz, S. H. Hasan, G. Neef & F. Ellendorff. 1988. Induction of parturition in the pig with the antigestagen ZK 112 993. Acta Endocrinol. (Suppl.) 287: 193. 24 Gazol, O. S., Y. Li, C. Schwabe & L. L. Anderson. 1993. Attenuation of antepartum relaxin surge and induction of parturition by antiprogesterone RU 486 in sheep. J. Reprod. Fertil. 97: 233–240. 25 Li, Y., R. Perezgrovas, O. S. Gazal, C. Schwabe & L. L. Anderson. 1991. Antiprogesterone, RU 486, facilitates parturition in cattle. Endocrinology 129: 765–770. 26 Van Look, P. F. A. & H. Von Hertzen 1993. Antiprogestogens: perspectives from a global research program. In Clinical Applications of Mifepristone (RU 486) and Other Antiprogestins. Assessing the Science and Recommending a Research Agenda. S. S. Brown & L. Z. Benet, Eds. 253–278. National Academy Press. Washington , DC . 27 Garfield, R. E. & S. Beier. 1989. Increased myometrial responsiveness to oxytocin during term and preterm labour. Am. J. Obstet. Gynecol. 161: 454–461. 28 Elger, W., M. Fähnrich, S. Beier, Shi Shao Qing & K. Chwalisz. 1987. Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs. Am. J. Obstet. Gynecol. 157: 1065–1074. 29 Chwalisz, K., F. Fahrenholz, M. Hackenberg, R. Garfield & W. Elger. 1991. The progesterone antagonist onapristone increases the effectiveness of oxytocin to produce delivery without changing the myometrial oxytocin receptor concentrations. Am. J. Obstet. Gynecol. 165 (6): 1760–1770. 30 Germain, G., D. Philibert, J. Pottier, M. Mouren, E. E. Baulieu & C. Sureau. 1985. Effect of the antiprogesterone agent RU 486 on the natural cycle and gestation in intact cynomolgus monkeys. In The Antiprogestin Steroid RU 486 and Human Fertility Control. E. E. Baulieu & S. J. Segal, Eds. 155–167. Plenum Press. New York . 31 Wolf, J. P., M. Sinosich, T. Anderson, A. Ulmann, E. E. Baulieu & G. D. Hodgen. 1989. Progesterone antagonist (RU 486) for cervical dilatation, labor induction, and delivery in monkeys: effectiveness in combination with oxytocin. Am. J. Obstet. Gynecol. 160: 45–47. 32 Wolf, J. P., J. Simon, J. Itskovitz, M. J. Sinosich, A. Ulmann, E. E. Baulieu & G. D. Hodgen. 1993. Progesterone antagonist RU 486 accommodates, but does not induce labour and delivery in primates. Hum. Reprod. 8: 759–763. 33 Haluska, G. J., F. Z. Stanczyk, M. J. Cook & M. J. Novy. 1987. Temporal changes in uterine activity and prostaglandin response to RU 486 in rhesus macaques in late gestation. Am. J. Obstet. Gynecol. 157: 1487–1495. 34 Novy, M. J. & G. J. Haluska. 1993. New perspectives on estrogen, progesterone, and oxytocin action in primate parturition. In Basic Mechanisms Controlling Term and Preterm Labor. Ernst Schering Research Foundation Workshop 7. K. Chwalisz & R. E. Garfield, Eds. 163–197. Springer Verlag. Berlin , Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest . 35 Glasier, A., K. J. Thong, M. Dewar, M. Mackie & D. T. Baird. 1992. Mifepristone (RU 486) compared with high-dose oestrogen and progestostogen for emergency postcoital contraception. N. Engl. J. Med. 327: 1041–1044. 36 Van Look, P. F. A. & M. Bygdeman. 1989. Antiprogestational steroids: a new dimension in human fertility regulation. Oxf. Rev. Reprod. Biol. 11: 1–60. 37 Urquhart, D. R. & A. A. Templeton. 1990b. The use of mifepristone prior to prostaglandin-induced mid-trimester abortion. Hum. Reprod. 5: 883–886. 38 Frydman, R., H. Fernandez, J. C. Pons & A. Ulmann. 1988. Mifepristone (RU 486) and late pregnancy termination: a double-blind study of two different doses. Hum. Reprod. 3: 803–806. 39 Hill, N. C. W., M. Selinger, J. Ferguson, A. López Bernal & I. Z. MacKenzie. 1990. The physiological and clinical effect of progesterone inhibition with mifepristone (RU 486) in the second trimester. Br. J. Obstet. Gynaecol. 97: 487–492. 40 Rodger, M. W. & D. Baird. 1990. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br. J. Obstet. Gynaecol. 97: 41–45. 41 Gottlieb, C. & M. Bygdeman. 1991. The use of antiprogestin (RU 486) for termination of second trimester pregnancy. Acta Obstet. Gynecol. Scand. 70: 199–203. 42 El-Rafaey, H., K. Hinshow & A. Templeton. 1993. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patient pre-treated with mifepristone (RU 486) Hum. Reprod. 8: 1744–1746. 43 Aubeny, E. & E. E. Baulieu. 1991. Contragestive activity of RU 486 and oral active prostaglandin combination. Comptes Rendus de l'Académie des Sciences 312: 539–545. 44 Thong, K. J. & D. T. Baird. 1992. A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy. Contraception 46: 11–17. 45 Cabrol, D., M. Bouvier D'Yvoire, E. Mermet, L. Cedard, C. Sureau & E. E. Baulieu. 1985. Induction of labour with mifepristone after intrauterine fetal death. Lancet 2: 1019. 46 Cabrol, D., C. Dubois, H. Cronje, J. M. Gonnet, M. Guillot, B. Maria, J. Moodley, J. F. Oury, J. M. Thoulon, A. Treisser, D. Ulmann, S. Correl & A. Ulmann. 1990. Induction of labour with mifepristone (RU 486) in intrauterine fetal death. Am. J. Obstet. Gynecol. 163: 540–542. 47 Frydman, R., C. Lelaidier, C. Baton-Saint-Mleux, H. Fernandez, M. Vial & P. Bourget. 1992. Labour induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study. Obstet. Gynecol. 80: 972–975. 48 Ulmann, A. & L. Silvestre. 1993. Uses of antiprogestins after 63 days of amenorrhoea. In Clinical Applications of Mifepristone (RU 486) and Other Antiprogestins. Assessing the Science and Recommending a Research Agenda. S. S. Brown & L. Z. Benet, Eds. 174–182. National Academy Press. Washington , DC . 49 Wolf, J. P., C. F. Chilik, J. Itskovitz, D. Weyman, T. L. Anderson, A. Ulmann, E. E. Baulieu & G. D. Hodgen. 1988. Transplacental passage of a progesterone antagonist in monkeys. Am. J. Obstet. Gynecol. 159: 328–342. 50 Hill, N. C. W., M. Selinger, J. Ferguson & I. Z. MacKenzie. 1991. Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy. Hum. Reprod. 6: 458–462. 51 Morgan, G. L., R. D. Geisert, J. P. McCann, F. W. Bazer, T. L. Ott, M. A. Mirando & M. Stewart. 1993. Failure of luteolysis and extension of interoestrus interval in sheep treated with the progesterone antagonist mifepristone (RU 486). J. Reprod. Fertil. 98 (2): 451–457. 52 Bazer, F. W. 1991. Uterine-conceptus interactions during the peri-implantation period. In Cellular Signals Controlling Uterine Function. L. A. Lavia, Ed. 119–137. Plenum Press. New York , London . 53 Wilson, T., G. C. Liggins, G. P. Aimer & S. J. M. Skinner. 1985. Partial purification and characterisation of two compounds from amniotic fluid which inhibit phospholipase activity in human endometrial cells. Biochem. Biophys. Res. Comm. 131 (1): 22–29. 54 Wilson, T., G. C. Liggins & L. Joe. 1989. Purification and characterization of a uterine phospholipase inhibitor that loses activity after labor onset in women. Am. J. Obstet. Gynecol. 160: 602–606. 55 Norman, J. E., R. W. Kelly & D. T. Baird. 1991. Uterine activity and decidual prostaglandin production in women in early pregnancy in response to mifepristone with or without indomethacin in vivo. Hum. Reprod. 6: 740–744. 56 Norman, J. E., W. X. Wu, R. W. Kelly, A. F. Glasier, A. S. McNeilly & D. T. Baird. 1991. Effects of mifepristone in vivo on decidual prostaglandin synthesis and metabolism. Contraception 44 (1): 89–98. 57 Cheng, L., R. W. Kelly, K. J. Thong, R. Hume & D. T. Baird. 1993. The effects of mifepristone (RU 486) on prostaglandin dehydrogenase in decidual and chorionic tissue in early pregnancy. Hum. Reprod. 8: 705–709. 58 Garfield, R. E. & E. L. Hertzberg. 1190. Cell-to-cell coupling in the myometrium: Emil Bozler's prediction. In Frontiers in Smooth Muscle Research. N. Sperelakis & J. D. Wood, Eds. 673–681. Wiley-Liss. New York . 59 Sakai, N., M. G. Blennerhassett & R. E. Garfield. 1992. Effects of antiprogesterones on myometrial cell-to-cell coupling in pregnant guinea pigs. Biol. Reprod. 46: 385–365. 60 Fuchs, A. R., F. Fuchs, P. Husslein, M. S. Soloff & M. Fernstrom. 1982. Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor. Science 215: 1396–1398. 61 Webster, M. A., N. S. Phipps & M. D. G. Gillmer. 1985. Myometrial activity in first trimeter human pregnancy after epostane therapy: effect of intravenous oxytocin. Br. J. Obstet. Gynaecol. 92: 957–962. 62 Swahn, M. L. & M. Bygdeman. 1988. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br. J. Obstet. Gynaecol. 95: 126–134. 63 Jacobson, L., R. K. Riemer, A. C. Goldfien, D. Lykins, P. K. Siiteri & J. M. Roberts. 1987. Rabbit myometrial oxytocin and α2-adrenergic receptors are increased by oestrogen but are differentially regulated by progesterone. Endocrinology 120: 1184–1189. 64 Yallampalli, C. D. V. M., H. Izumi, M. M. S. Byam-Smith & R. E. Garfield. 1994. An l-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am. J. Obstet. Gynecol. 170: 175–185. 65 Izumi, H., C. Yallampali & R. E. Garfield. 1993. Gestational changes in l-arginine-induced relaxation of pregnant rat and human myometrial smooth muscle. Am. J. Obstet. Gynecol. 169: 1327–1337. 66 Tezuka, N., M. Ali, K. Chwalisz & R. E. Garfield. 1993. Increased mRNA levels for the L-type Ca2++ channels in rat myometrium prior to term and preterm labor. Physiologist 36 (5). APS Conference: Signal Transduction and Gene Regulation, November 17–20, 1993, San Francisco, California (Abstract 5.25). 67 Leppert, P. C. 1992. Cervical softening, effacement and dilatation: a complex biochemical cascade. J. Mat. Fet. Med. 1: 213–223. 68 Chwalisz, K., C. Hegele-Hartung, R. Schulz, Shi Shao Qing, P. T. Louton, & W. Elger. 1991. Progesterone control of cervical ripening—experimental studies with the progesterone antagonists onapristone, lilopristone and mifepristone. In The Extracellular Matrix of the Uterus, Cervix and Fetal Membranes: Synthesis, Degradation and Hormonal Regulation. P. Leppert & F. Woessner, Eds. 119–131. Perinatology Press. 69 Hegele-Hartung, C., K. Chwalisz, H. M. Beier & W. Elger. 1989. Ripening of the uterine cervix of the guinea pig after treatment with the progesterone antagonist onapristone (ZK 98 299): an electron microscopic study. Hum. Reprod. 4: 369–377. 70 Durlot, F., C. Dubois, J. Brunerie & Frydman, A 1988. Efficacy of progesterone antagonist RU 486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion. Hum. Reprod. 3: 583–584. 71 Radestadt, A., N. J. Christensen & L. Strömberg. 1988. Induced cervical ripening with mifepristone in first trimester abortion: a double-blind randomized biochemical study. Contraception 38: 101–112. 72 World Health Organization. 1990. The use of mifepristone (RU 486) for cervical preparation in the first trimester pregnancy termination by vacuum aspiration. Br. J. Obstet. Gynaecol. 97: 260–266. 73 Urquhart, D. R. & A. A. Templeton. 1990. Mifepristone (RU 486) for cervical priming prior to surgically induced abortion in the late first trimester. Contraception 42: 191–199. 74 Gupta, J. K. & N. Johnson. 1990. Effect of mifepristone on dilatation of the pregnant and nonpregnant cervix. Lancet 335: 1238–1240. 75 Rajabi, M., S. Solomon & R. Poole. 1991. Biochemical evidence of collagenase-mediated collagenolysis as a mechanism of cervical dilatation at parturition in the guinea pig. Biol. Reprod. 45: 764–772. 76 Rajabi, M., S. Solomon & R. Poole. 1991. Hormonal regulation of interstitial collagenase in the uterine cervix of the pregnant guinea pig. Endocrinology 128: 863–871. 77 Granström, L. M., E. E. Gunvor, A. Malmström, U. Ulmsten & J. F. Woessner. 1992. Serum collagenase levels in relation to the state of the human cervix during pregnancy and labour. Am. J. Obstet. Gynecol. 167: 1284–1288. 78 Marbaix, E., J. Donnez, P. J. Courrtoy & Y. Eeckhout. 1992. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc. Natl. Acad. Sci. USA 89: 11789–11793. 79 Bukowski, R., G. Roth & K. Chwalisz. 1994. Lipopolysaccharide (LPS-endotoxin) induces cervical ripening in pregnant guinea pigs: a process mediated by prostaglandins. Soc. Gynecol. Invest., March 2326 1994. Chicago , IL . Scientific Program and Abstracts (abstract). 80 Cabrol, D., B. Carbonne, A. Bienkiewicz, E. Dallot, A. E. Ali & L. Cedard. 1991. Induction of labour and cervical maturation using mifepristone (RU 486) in the late pregnant rat. Influence of a cyclooxygenase inhibitor (diclofenac). Prostaglandins 42: 71–79. 81 Radestadt, A. & M. Bygdeman. 1992. Cervical softening with mifepristone (RU 486) after pretreatment with naproxen. A double-blind randomized study. Contraception 45: 221–227. 82 Liggins, G. C. 1981. Cervical ripening as an inflammatory reaction. In The Cervix in Pregnancy and Labour. D. A. Ellwood & A. B. M. Anderson, Eds. 1–19. Churchill Livingstone. Edinburgh . 83 Jungueira, L. C. U., M. Zugaib, G. S. Montes, O. M. S. Toledo, R. M. Krisztan & K. M. Shigihara. 1980. Morphologic and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophylic polymorphonuclear leukocytes during cervical dilatation. Am. J. Obstet. Gynecol. 138: 273. 84 Hiro, D., D. Hioro, Y. Ojima & Y. Mori. 1988. Spontaneous production of interleukin 1-like factors from pregnant rabbit uterine cervix. Am. J. Obstet. Gynecol. 159: 261–265. 85 Barcley, C. G., J. E. Brennand, R. W. Kelly & A. A. Calder. 1993. Interleukin-8 production by the human cervix. Am. J. Obstet. Gynecol. 169: 625–632. 86 Kelly, R. W., R. Leask & A. A. Calder. 1992. Choriodecidual production of interleukin-8 and the mechanism of parturition. Lancet 339: 776–777. 87 Chwalisz, K., P. Scholz, Ch. Hegele-Hartung, G. Roth & R. Bukowski. 1993b. Cervical ripening with interleukin 1β (IL-1β) and tumor necrosis factor-α (TNF-α) in pregnant guinea pigs. Soc. Gynecol. Invest. Scientific Program and Abstracts, 40th Annual Meeting, March 31-April 3, 1993. Toronto , Ontario . Abstract S27. 88 Bukowski, R., P. Scholz, S. H. Hasan & K. Chwalisz. 1993. Induction of preterm parturition with the interleukin 1β, tumor necrosis factor-α (TNF-α) and with LPS in guinea pigs. Soc. Gynecol. Invest. Scientific Program and Abstracts, 40th Annual Meeting, March 31-April 3, 1993. Toronto , Ontario . Abstract S26. 89 Casey, M. L. & P. C. MacDonald. 1993. Transforming growth factor-β (TGF-β) acts as a gene-specific antiprogestin. Soc. Gynecol. Invest. Scientific Program and Abstracts, 40th Annual Meeting, March 31-April 3, 1993. Toronto , Ontario . Abstract S2. Citing Literature Volume734, Issue1The Human EndometriumSeptember 1994Pages 387-413 ReferencesRelatedInformation